Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Jérome Fayette"'
Autor:
Grégoire Marret, Stéphane Temam, Maud Kamal, Caroline Even, Jean-Pierre Delord, Caroline Hoffmann, Gilles Dolivet, Olivier Malard, Jérôme Fayette, Olivier Capitain, Sébastien Vergez, Lionel Geoffrois, Frédéric Rolland, Philippe Zrounba, Laurent Laccourreye, Esma Saada-Bouzid, Nicolas Aide, Valérie Bénavent, Jerzy Klijianenko, Constance Lamy, Elodie Girard, Sophie Vacher, Julien Masliah-Planchon, Leanne de Koning, Vincent Puard, Edith Borcoman, Marta Jimenez, Ivan Bièche, Jocelyn Gal, Christophe Le Tourneau
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-15 (2023)
Abstract There is no strong and reliable predictive biomarker in head and neck squamous cell carcinoma (HNSCC) for EGFR inhibitors. We aimed to identify predictive and pharmacodynamic biomarkers of efficacy of afatinib, a pan-HER tyrosine kinase inhi
Externí odkaz:
https://doaj.org/article/71b235740be44697822692560686e4ae
Autor:
Chantal Rigal, Sepharine Visozo, Caroline Hernandez, Sophie Seité, Ellen Blanc, Camille Schiffler, Jérome Fayette, Ann’laure Demessant, Azita Sarve
Publikováno v:
Annales de Dermatologie et de Vénéréologie - FMC. 1:A340
Introduction Les iEGFR largement utilises pour le traitement de certaines tumeurs malignes solides avancees, entrainent frequemment des toxicites cutanees. Ces toxicites peuvent conduire a une reduction de la dose ou a l’arret du traitement contre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::da1a40550810476a71abeee26b75f15a
https://doi.org/10.1016/j.fander.2021.09.407
https://doi.org/10.1016/j.fander.2021.09.407
Autor:
Agathe Vienne, Laetitia Collet, Thomas Chevalier, Christian Borel, Magalie Tardy, Florence Huguet, Sandrine Richard, Sebastien Salas, Esma Saada-Bouzid, Jerome Fayette, Amaury Daste
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-6 (2023)
Abstract Background Patients with recurrent or metastatic head and neck squamous cell carcinoma (R/M-HNSCC) have a poor prognosis and limited therapeutic options. Immune checkpoint inhibitors (ICIs) are effective in patients with tumor progression
Externí odkaz:
https://doaj.org/article/2388ba0bba194bddb439359010ce02cf
Autor:
Juliette Dessemon, Olivia Perol, Cécile Chauvel, Hugo Noelle, Thomas Coudon, Lény Grassot, Nicolas Foray, Elodie Belladame, Jérôme Fayette, Françoise Fournie, Aurélie Swalduz, Eve-Marie Neidhart, Pierre Saintigny, Mayeul Tabutin, Maxime Boussageon, Frédéric Gomez, Virginie Avrillon, Maurice Perol, Barbara Charbotel, Béatrice Fervers
Publikováno v:
Frontiers in Public Health, Vol 11 (2024)
IntroductionResidential exposure is estimated to be responsible for nearly 10% of lung cancers in 2015 in France, making it the second leading cause, after tobacco. The Auvergne-Rhône-Alpes region, in the southwest of France, is particularly affecte
Externí odkaz:
https://doaj.org/article/59eed2ed0592472bacd7aa9539ba0b7b
Autor:
Christian Borel, Caroline Even, Christophe Le Tourneau, Jerome Fayette, Laurence Bozec, Joël Guigay, Sylvie Chabaud, Laurence Digue, Lionnel Geoffrois, Fréderic Rolland, Didier Cupissol, Anne Françoise Dillies, Sylvie Zanetta, Sophie Couchon-Thaunat, Valérie Costes-Martineau, Anne Sudaka-Bahadoran, Isabelle Jallut, Florence Garic, Audrey Lardy-Cleaud
Publikováno v:
BMJ Oncology, Vol 2, Iss 1 (2023)
Objective Salivary gland cancers (SGC) are rare cancers with currently no standard treatment for recurrent/metastatic disease. Based on checkpoint inhibitors benefit in a broad range of tumours, NIvolumab in Salivary gland CArcinoma of the Head and N
Externí odkaz:
https://doaj.org/article/052fd89043554401a71844df62d952d0
Autor:
Bao-Tram Thi Tran, Aurore Gelin, Sylvère Durand, Matthieu Texier, Amaury Daste, Clémence Toullec, Karim Benihoud, Ingrid Breuskin, Philippe Gorphe, Florence Garic, Catherine Brenner, Christophe Le Tourneau, Jérôme Fayette, Toshiro Niki, Muriel David, Pierre Busson, Caroline Even
Publikováno v:
OncoImmunology, Vol 12, Iss 1 (2023)
ABSTRACTExtra-cellular galectins 1, 3 and 9 (gal-1, −3 and −9) are known to act as soluble immunosuppressive agents in various malignancies. Previous publications have suggested that their expression is dependent on the metabolic status of produc
Externí odkaz:
https://doaj.org/article/719766cfc1884b85a06769ebea03df1c
Autor:
Bétrian, Sarah, Bergeron, Christophe, Jean-Yves Blay, Bompas, Emmanuelle, Cassier, Philippe, Chevallier, Laure, Jérome Fayette, Girodet, Magali, Guillemet, Cécile, Cesne, Axel Le, Marec-Berard, Perrine, Ray-Coquard, Isabelle, Chevreau, Christine
Additional file 2. CNIL (Comité National d’Information et Libertés) French committee in charge of watching that the computing is in the service of the citizen and that it strikes a blow neither at the human identity, nor at the human rights, nor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ace757c73ae4b10da9982ffc43d50a3
Autor:
Coauthor(s) Thibault Gauduchon, Cécile Dalban, Zrounba Philippe, Séverine Racadot, Sylvie Chabaud, Emile Reyt, Marc Poupart, Jean Michel Prades, Michael Burgy, Dominique Cellier, Philippe Ceruse, Jacques Leval, Philippe Muller, Patrick Manipoud, Isabelle Ray-Coquard, Jérôme Fayette
Publikováno v:
Oral Oncology Reports, Vol 6, Iss , Pp 100042- (2023)
Background: The initial curative standard treatment for LAHNSCC is exclusive CRT (chemoradiotherapy) or surgery ( ± CRT) which give similar results in term of PFS and OS. Indication depends on several factors including regional expertise and a
Externí odkaz:
https://doaj.org/article/dc089b916e9e46d08a63c97c9235e8f6
Autor:
Jean-Philippe Foy, Andy Karabajakian, Sandra Ortiz-Cuaran, Maxime Boussageon, Lucas Michon, Jebrane Bouaoud, Dorssafe Fekiri, Marie Robert, Kim-Arthur Baffert, Geneviève Hervé, Pauline Quilhot, Valéry Attignon, Angélique Girod, André Chaine, Mourad Benassarou, Philippe Zrounba, Christophe Caux, François Ghiringhelli, Sylvie Lantuejoul, Carole Crozes, Isabelle Brochériou, Maurice Pérol, Jérôme Fayette, Chloé Bertolus, Pierre Saintigny
Publikováno v:
Data in Brief, Vol 44, Iss , Pp 108556- (2022)
Identification of tumors harboring an overall active immune phenotype may help for selecting patients with advanced head and neck squamous cell carcinomas (HNSCC) and non-small cell lung cancer (NSCLC) who may benefit from immunotherapies. In this co
Externí odkaz:
https://doaj.org/article/dc4e546ef4f94d60bcf8550d81ded5eb
Autor:
Thomas Chevalier, Amaury Daste, Esmaa Saada‐Bouzid, Anderson Loundou, Florent Peyraud, Tiphaine Lambert, Christophe Le Tourneau, Frédéric Peyrade, Charlotte Dupuis, Marc Alfonsi, Jérôme Fayette, Juliette Reure, Florence Huguet, Nicolas Fakhry, Clémence Toullec, Sébastien Salas
Publikováno v:
Cancer Medicine, Vol 10, Iss 12, Pp 3952-3963 (2021)
Abstract BACKGROUND Prognosis of recurrent or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) remains poor. The addition of cetuximab, to platinum and fluorouracil chemotherapy (EXTREME regimen) has been shown to improve patients’ ou
Externí odkaz:
https://doaj.org/article/5723658a1a9f4460a7ff6b0ae310d7cc